| 19.695 0.245 (1.26%) | 10-15 12:19 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 23.98 | 1-year : | 25.26 |
| Resists | First : | 20.53 | Second : | 21.62 |
| Pivot price | 20.13  |
|||
| Supports | First : | 18.77 | Second : | 15.61 |
| MAs | MA(5) : | 19.52 |
MA(20) : | 20.31 |
| MA(100) : | 20.04 |
MA(250) : | 19.37 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 24.9 |
D(3) : | 16.5 |
| RSI | RSI(14): 42.4 |
|||
| 52-week | High : | 23 | Low : | 14.22 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ NVST ] has closed above bottom band by 30.3%. Bollinger Bands are 11.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 19.59 - 19.66 | 19.66 - 19.75 |
| Low: | 18.57 - 18.65 | 18.65 - 18.74 |
| Close: | 19.3 - 19.43 | 19.43 - 19.58 |
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
Tue, 14 Oct 2025
Envista Holdings (NVST): Evaluating Valuation as Profitability Returns and Analysts Hold Steady After Latest Results - simplywall.st
Tue, 14 Oct 2025
Envista Q2 2025 presentation: Core growth accelerates, company raises full-year guidance - Investing.com
Tue, 14 Oct 2025
Earnings call transcript: Envista Holdings reports Q2 2025 growth and raises guidance - Investing.com UK
Sat, 11 Oct 2025
Jefferies Sticks to Their Hold Rating for Envista Holdings (NVST) - The Globe and Mail
Fri, 10 Oct 2025
Assessing Envista After Recent Earnings Miss and Share Price Discount in 2025 - simplywall.st
Thu, 09 Oct 2025
Envista Holdings (NVST): Evaluating Market Valuation Following Recent Modest Share Price Gain - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Equipment & Services
|
|
| Shares Out | 166 (M) |
| Shares Float | 166 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 119.6 (%) |
| Shares Short | 9,100 (K) |
| Shares Short P.Month | 9,680 (K) |
| EPS | 0.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.81 |
| Profit Margin | 2.1 % |
| Operating Margin | 7.4 % |
| Return on Assets (ttm) | 2.2 % |
| Return on Equity (ttm) | 1.7 % |
| Qtrly Rev. Growth | 7.6 % |
| Gross Profit (p.s.) | 8.48 |
| Sales Per Share | 15.34 |
| EBITDA (p.s.) | 1.86 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 292 (M) |
| Levered Free Cash Flow | 267 (M) |
| PE Ratio | 61.64 |
| PEG Ratio | 0 |
| Price to Book value | 1.04 |
| Price to Sales | 1.28 |
| Price to Cash Flow | 11.22 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|